Memorabilia of Sunflower Pharmaceutical Group (Hengshui) Defeier Co., Ltd.

On July 26th, 20001year, the company was established, which belongs to Hebei Jiheng Group.

In 2002, Nanchang achieved the first certification of injection and oral liquid, and obtained the "passport" for market access.

In 2003, our west factory realized the first certification of three dosage forms: granules, tablets and capsules;

In 2004, Nanchang achieved the first certification of suppositories, ointments and traditional Chinese medicine granules;

On June 14, 2004, the first pharmaceutical factory of Hebei (Jiheng Group) Huawei Pharmaceutical Co., Ltd. was renamed as Hebei Huawei Postpone Pharmaceutical Co., Ltd. with Liu Haigang as the legal representative and Liu Haigang as the person in charge.

At the end of 2005, it completed the restructuring and officially became an independent joint-stock pharmaceutical enterprise.

In 2006, West Factory obtained the first powder dry suspension certification;

In August 2007 and February 2007, 65438+2007, the re-certification of injections and oral liquids in Nanchang was realized.

At the end of 2007, Warwick Delphi Pharmaceutical Co., Ltd. cooperated with the foreign New Zealand Reginald Family Trust Fund to establish a Sino-foreign joint venture.

In 2008, West Factory realized the recertification of three dosage forms: granules, tablets and capsules.

20 10 On April 22nd, Sunflower Pharmaceutical Group acquired Reggiani Family Trust Fund, the major shareholder of Delphi Pharmaceutical, and officially became the controlling shareholder of Delphi Pharmaceutical.

20 10 officially changed its name to sunflower pharmaceutical group (Hengshui) Delphi co., ltd on April 30th.